FUROSEMIDE S.A.L.F 20 MG 2 ML

Država: Izrael

Jezik: angleščina

Source: Ministry of Health

Aktivna sestavina:

FUROSEMIDE

Dostopno od:

RAZ PHARMACEUTICS LTD, ISRAEL

Koda artikla:

C03CA01

Farmacevtska oblika:

SOLUTION FOR INJECTION / INFUSION

Sestava:

FUROSEMIDE 10 MG/ML

Pot uporabe:

I.M, I.V

Tip zastaranja:

Required

Izdeluje:

S.A.L.F. S.P.A. LABORATORIO FARMACOLOGICO, ITALY

Terapevtsko območje:

FUROSEMIDE

Terapevtske indikacije:

Furosemide S.A.L.F 20mg/2ml is a potent diuretic indicated for use when a prompt and effective diuresis is required.Furosemide S.A.L.F 20mg/2ml is appropriate for use in emergencies or where oral therapy is not feasible.The indications include cardiac, pulmonary, hepatic and renal oedema.

Datum dovoljenje:

2022-07-31

Navodilo za uporabo

בוחר ,"סרגורפ זר" ןינב ,מ"עב תוחקור זר
תכתמה
6
,
זא
ת"ה
המידק
.
:'לט
09-8307301
:סקפ ;
09-8987883
:ליימ ;
[e-mail]
טסוגוא
2019
ה/דבכנ ה/אפור
,
ת/דבכנ ת/חקור
, םכעידוהל תשקבמ תוחקור זר תרבח ןוכדע לע
:רישכתה לש אפורל ןולעה
FUROSEMIDE S.A.L.F 20MG/2ML
.אפורל ןולעב םייתוהמ םייוניש ושענ םהב
םיפיעסה קר םיניוצמ וז העדוהב
תופסותה
עבצב ונמוס
,
ה
עבצב ונמוס תוקיחמ
א
םוד
םע
.הקיחמ וק
:תואירבה דרשמ רתאבש תופורתה רגאמב
ומוסרפ ךרוצל תואירבה דרשמל חלשנ
ןכדועמה ןולעה
www.health.gov.il
:םושירה לעבל היינפ ידי לע ספדומ ולבקל
ןתינו
תכתמה בוחר ,מ"עב תוחקור זר
6
.המידק .ת.א ,
,הכרבב
ןומימ לאירא
הנוממ תחקור
F 20MG/2ML
FUROSEMIDE S.A.L.
ליעפ ביכרמ
קזוחו
:
Furosemide 20mg/2ml
:תרשואמ היוותה
Furosemide S.A.L.F 20 mg/2ml is a potent diuretic indicated for use
when a prompt and effective
diuresis is required. Furosemide S.A.L.F 20mg/2ml is appropriate for
use in emergencies or when
oral therapy is not feasible. Indications include cardiac, pulmonary,
hepatic and renal edema.
אפורל ןולעב םינוכדעה
:
6.1
INCOMPATIBILITIES
Furosemide S.A.L.F 20 mg/2 ml can be diluted with glucose 5%, isotonic
sodium chloride or Ringer lactate
solutions.
Furosemide S.A.L.F 20mg/2ml solution should not be mixed with any
other drugs in the injection bottle (see
clause 6.6).
6.2
SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING
Furosemide S.A.L.F 20 mg/2 ml can be diluted with glucose 5%,
isotonic sodium chloride or Ringer lactate
solutions.
In case of dilution: Do not freeze. The product is stable for 8 hours
with no special storage conditions, but from
a microbiological point of view, the product should be used
immediately.
If not

Lastnosti izdelka

SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE DRUG
Furosemide S.A.L.F 20mg/2ml
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml of solution contains Furosemide 10 mg.
Each 2 ml ampoule contains Furosemide 20 mg.
For a full list of the excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Solution for injection.
clear, colourless to almost colourless solution and free of
visible particles.
4. CLINICAL INFORMATION
4.1. THERAPEUTIC INDICATIONS
Furosemide S.A.L.F 20mg/2ml is a potent diuretic indicated for
use
when
a
prompt
and
effective
diuresis
is
required.
Furosemide
S.A.L.F
20mg/2ml
is
appropriate
for
use
in
emergencies
or
when
oral
therapy
is
not
feasible.
The
indications
include
cardiac,
pulmonary,
hepatic
and
renal
oedema.
_ _
4.2. POSOLOGY AND METHOD OF ADMINISTRATION
Route of administration: intramuscular or intravenous use.
_Adults _
Intravenous furosemide must be injected or infused slowly; a
rate of 4 mg per minute must not be exceeded. In patients
with severe impairment of renal function (serum creatinine
>5 mg/dl), it is recommended that an infusion rate of 2.5 mg
per minute is not exceeded.
Intramuscular
administration
must
be
restricted
to
exceptional
cases
where
neither
oral
nor
intravenous
administration
is
feasible.
It
must
be
noted
that
intramuscular injection is not suitable for the treatment of
acute conditions such as pulmonary oedema.
To
achieve
optimum
efficacy
and
suppress
counter-
regulation, a continuous furosemide infusion is generally to
be preferred to repeated bolus injections. Where continuous
furosemide infusion is not feasible for follow-up treatment
after one or several acute bolus doses, a follow-up regimen
with low doses given at short intervals (approximately four
hours) is to be preferred to a regimen with higher bolus
doses at longer intervals.
Doses of 20 to 50 mg intramuscularly or intravenously may
be given initially. If larger doses are required, they should be
given by 20 mg increments and not given more often than
every two hours. If doses greater than 50 mg are req